National Working Group on Microbicides The Basics of Microbicides Amitrajit Saha PATH January 2007.

Slides:



Advertisements
Similar presentations
HIV/AIDS The Epidemic in ANE and E&E So what do we do now? Paul De Lay Senior Advisor on HIV/AIDS Office of HIV/AIDS.
Advertisements

What does sexual & reproductive health have to do with clinical trials? Providing contraception & reproductive health care helps.
No one left behind: Increased coverage, better programmes and maximum impact for key populations WHO Consolidated Guidelines on HIV Prevention, Diagnosis,
Women and ARV-based Prevention: Challenges and Opportunities Tim Mastro, MD, DTM&H AIDS 2014 Melbourne, Australia 24 July 2014.
STDs Valerie Robinson D.O.. Prevention Abstinence Risk reduction Vaccines Male or female condoms Cervical diaphragm might protect against cervical GC,
PrEP: HIV Pre-exposure Prophylaxis Katherine Marx, MS, MPH, FNP-BC June 2014.
Cristin Muecke, RMOH Nick Scott, ED AIDS NB.  Why HIV testing remains important  Treatment as prevention  Discuss advantages/disadvantages of various.
Dr. Carol Odula (Obs./Gyn.) May 7 th 2013 Preparing for pre-exposure prophylaxis (PrEP) to prevent HIV infection.
From “What If” to “What Now” Perspectives on ARVs and the Future of Treatment and Prevention Mitchell Warren Executive Director, AVAC IAS 2011, Rome.
Microbicides Envision a product that could save lives Your name here
Preparing for pre-exposure prophylaxis (PrEP) to prevent HIV infection James Wilton Project Coordinator Biomedical Science of HIV Prevention
HIV in Texas: The Ways Forward Ann Robbins Manager of HIV/STD Prevention and Care Department of State Health Services.
Hadiyah Charles, Community HIV/AIDS Mobilization Project Naina Khanna, WORLD/U.S. Positive Women’s Network HIV Research Catalyst Forum April 21, 2010.
Doing the Right Thing Karen A. Stanecki XV International AIDS Conference.
HIV and Reproductive Health? William Stones. Questions What is reproductive health? Is HIV best approached as a RH topic? What are the pros and cons of.
Rectal Microbicides: The Basics Date, Location Your name, Your affiliation.
 Chapter 30  African American College Age Women  Group 8  By: Filiz Erenguc Leyla Goldsmith Shameka Showers Katie Wallace.
Are people living with HIV less likely to pass HIV to others if they are on treatment? Exploring the use of treatment as prevention James Wilton Project.
Dr Himani. Foams or creams that people can use in vagina or rectum during sex to prevent transmission Currently, there is no vaccine to prevent HIV. This.
Myths and Misconceptions
Rectal Microbicides: The Basics Date, Location Your Name, Organization.
Jim Pickett, IRMA/AFC GMHC – January 23, 2013 The Bottom Line on Rectal Microbicide Research.
HIV AIDS Section Fabienne Hariga Senior Adviser UNODC HIV AIDS section, Vienna Comprehensive package of interventions for HIV in prison settings AIDS 2012.
Midwest AIDS Training & Education Center Health Care Education & Training, Inc. HIV/AIDS Case-Finding In Family Planning Clinics.
STIs/HIV/AIDS. ( 2 ) Sexually transmitted infections (STIs) are spread primarily through sexual contact and are among the most common diseases in the.
Sexually Transmitted Infections & HIV/AIDS
HIV & AIDS. HIV INFECTION HIV-The most serious incurable STI HIV-Human Immunodeficiency Virus.
EngenderHealth/UNFPA Project – Ethiopia/Ukraine Strengthening the integration of HIV prevention in maternal health services. Increasing the capacity of.
Introduction to HIV New Prevention Technologies (NPTs)
Microbicides: New Hope for Prevention of HIV and other STIs
Microbicides: Who, what, where, when and how Rebekah Webb Global Campaign for Microbicides © Salam Dahbor,
Rectal Microbicides: New Hope for Non-Condom Prevention of HIV and other STDs.
HIV/AIDS BI-ANNUAL REVIEW 2008 Prevention -Goal, Indicators and Targets TACAIDS.
One-size does not fit all: Importance of all- inclusive HIV prevention HIV-Prevention:update on global and Finnish HIV situation and new preventive technologies.
Biomedical Approaches to HIV Prevention HIV Research Catalyst Forum April 21, 2010, Baltimore, MD Monica S. Ruiz, PhD, MPH George Washington University.
Microbicides: Science, research, and overview of the field Dr Kamini Walia, Indian Council of Medical Research, New Delhi Bindiya Patel, Global Campaign.
Resource Needs Model Rachel Sanders October 28 th, 2010.
HIV/AIDS IN PERU. Map General statistics Population million Life expectancy: Male: years Female: 75.6 years GNI billion Literacy.
Rectal Microbicides: New Hope for HIV and STD Prevention.
Microbicides: What will they do? What will they be like? What needs to be done? Richard A. Cone Johns Hopkins University ReProtect, LLC (“BufferGel™” &
Office of Global Health and HIV (OGHH) Office of Overseas Programming & Training Support (OPATS) Session: Voluntary Medical Male Circumcision (VMMC)
HIV Prevention : Why we need more options for women Wanjiku Kamau Consultant: International AIDS Vaccine Initiative Consultant: International Partnership.
Partnering to Promote Female-controlled HIV Prevention Methods Matthews J, Becker J, Massey C, Jacobsen J, Patel B Ibis Reproductive Health, International.
INVESTING TO END THE AIDS EPIDEMIC: A NEW ERA FOR HIV RESEARCH & DEVELOPMENT HIV VACCINES WORKING GROUP & MICROBICIDES RESOURCE TRACKING E. Donaldson 1,
AIDS PREVALENCE IN THE WORLD. AIDS EVAPORATES GAINS OF THE 20 TH CENTURY IN AFRICA.
Rectal microbicides, where are we? Kim Mulji Naz Foundation International.
Expanding Prevention Options for Women and Girls Deirdre Grant, AIDS Vaccine Advocacy Coalition Arwa Meijer, Global Campaign for Microbicides Kimberly.
1 HIV and AIDS Data Hub for Asia-Pacific Review in slides Singapore.
10 facts about AIDS Source: World Health Organization
Eastern European Alliance for Reproductive Choice REPRODUCTIVE CHOICE FOR HIV- INFECTED WOMEN Prof. POSOKHOVA S.P. UKRAINE УКРАЇНАУКРАЇНА.
A Jo Robinson, Terrence Higgins Trust in cooperation with the Global Campaign for Microbicides Topical.
Microbicides: New Hope for Prevention of HIV and other STIs Pamina M. Gorbach UCLA- SPH & Medicine.
Topical Microbicides: New Hope for Non-Condom Prevention of HIV and other STDs Your name here on behalf of the Global Campaign.
Session: 3 The four pronged approach to comprehensive prevention of HIV in infants and young children Dr.Pushpalatha, Assistant Professor, Dept of Pediatrics,
Pagare Maya & Yewale Sakhu. 1. We aimed at desiging on all purpose 9 th and 10 th std. students give the information of aids. Create the scientific attitude.
A pill to prevent HIV? For women??
New ARV-based prevention tools how the research is happening how we need to be involved Anna Forbes, MSS Consultant, HIV and women’s health HIV Research.
Effective HIV & SRH Responses among Key Populations Module 2: The Comprehensive Package of Programmes and Services.
A people-centred perspective Dr Roger Tatoud Imperial College London IRMA Global Teleconference 4 December 2009.
New Prevention Technologies Workshop Module 2: NPTs in context
Effective HIV & SRH Responses Among Sex Workers and other Key Populations Module 2: A Comprehensive Package of Services for Key Populations.
Microbicides: New Hope for Prevention of HIV and other STIs Your name here
Prevention Science Gaps and the HIV/AIDS Pandemic Quarraisha Abdool Karim, PhD Head: CAPRISA Women and AIDS Pogramme Associate Professor in Epidemiology,
HIV/AIDS Epidemic in India Trends, Lessons, Challenges & Opportunities
IAS Satellite Session 25th July 2017 Daniel Were, PhD
WHO strategy on HIV/AIDS “Getting to Zero”
STRATEGIES FOR STI PREVENTION AND CONTROL
HIV/AIDS in India World AIDS Day 2006 December 1
HIV/AIDS Prevenetion & Awareness
Microbicides: Who, what, where, when and how
Presentation transcript:

National Working Group on Microbicides The Basics of Microbicides Amitrajit Saha PATH January 2007

National Working Group on Microbicides What is a microbicide? Currently, they are being formulated as gels or creams applied with an applicator. Future formulations could include sponges, time-released vaginal rings or gels combined with barrier devices such as diaphragms or cervical caps. Microbicides are substances that can reduce the transmission of HIV and other STI pathogens when applied vaginally and, possibly, rectally. They are not yet available.

National Working Group on Microbicides Is there a need for microbicides?  Rising rates of HIV infections: 37.8 million people are infected worldwide (UNAIDS ‘04 report on the Global AIDS epidemic)  5.21 million people living with HIV/AIDS in India at the end of ‘05 (NACO)  STI prevalence of 22% in women attending RH clinic in New Delhi (Sex Trans Inf, ‘00)  Feminization of HIV  6/10 new infections are among women. Almost 50% of all infected people worldwide are women (UNAIDS)  39% of people living with HIV in India at the end of 2005 were women (NACO)

National Working Group on Microbicides  Women are biologically more vulnerable to HIV/AIDS  2-4 times more likely than men to get HIV from unprotected sex  Women may be less able to assert their rights  Economic need or dependency  Social and cultural norms  Gender-based violence  Current methods – abstinence, fidelity, and condom use – are limited and often require male consent, knowledge or cooperation  The power dynamics between MSM means that for example, the kothi population are often unable to negotiate safe sex Is there a need for microbicides?

National Working Group on Microbicides Comprehensive Strategies for Protection Protection Technology Economic Opportunities Social Power Source: Brady, Martha. Population Council, Conceptual Framework

National Working Group on Microbicides Microbicides would work by:  Killing or inactivating the pathogen (germ)  Creating a barrier between pathogen and vulnerable tissue  Interfering with entry of virus into target cell  Preventing replication once virus has entered the cell( ARV based)  Boosting the vagina’s natural defenses Eventually microbicides will combine two or more mechanisms of action

National Working Group on Microbicides 2. surfactants 3. entry inhibitors 4. anti-retrovirals 1. boosts vagina’s natural defenses Source: Shattock, R.; Moore, J. Inhibiting Sexual Transmission of HIV-1 Infection. Nature Reviews Microbiology. Vol 1, October 2003.

National Working Group on Microbicides What would vaginal microbicides be like?  Contraceptive or non-contraceptive  Coitally-dependent and -independent  May reduce risk of other STIs  Likely to be inexpensive and available over the counter  Could be used without partner’s cooperation or even awareness

National Working Group on Microbicides How could microbicides benefit people living with HIV/AIDS?  Could reduce risk of co-infection with other HIV strains  May help protect both partners  Could reduce risk of other STIs, yeast and bladder infections  May allow conception while protecting partner

National Working Group on Microbicides Microbicides & anal sex  Many people (women and men) need microbicides for anal sex  Creating an effective rectal microbicide is scientifically more complicated  Vaginal microbicides must be accurately labeled Image courtesy of

National Working Group on Microbicides Microbicides are a part of a spectrum of HIV prevention and treatment options Prior to exposure Point of transmission Treatment Behavior change Sterile syringe access and drug addiction treatment Blood safety STI screening and treatment Voluntary counseling and testing Vaccines Pre-exposure prophylaxis (PREP) Male circumcision Male and female condoms Anti-retroviral (ARV) therapies to reduce mother-to-child transmission Vaginal & rectal microbicides Cervical barrier Diaphragms Anti-retroviral (ARV) therapies Opportunistic infection therapies Basic care/ nutrition Post-exposure prophylaxis (PEP)

National Working Group on Microbicides Balancing act to minimize HIV risk condoms reduces risk by 80-90% ? consistency of use microbicides may reduce risk by 40-60% ? consistency of use

National Working Group on Microbicides Thank You